Phreesia appoints Dr. Lisa Egbuonu-Davis to Board and adopts 2023 Inducement Award Plan

Phreesia, Inc.

Appointed Dr. Lisa Egbuonu-Davis as Class II director effective July 13, 2023, to serve until 2024 annual meeting.
Received pro-rated annual RSU grant valued at $177,418, vesting on the earlier of one year or next annual meeting.
Received additional new hire RSU grant valued at $185,000 with a four-year graded vesting schedule.
Board adopted 2023 Inducement Award Plan reserving 500,000 shares for grants to new employees and executives.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Lisa Egbuonu-Davis

Director

PHR · Phreesia, Inc.

Effective: 2023-07-13
Filed: July 13, 2023, 7:59 PM ET

On July 13, 2023, the Board of Directors (the "Board") of Phreesia, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Lisa Egbuonu-Davis to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Lisa Egbuonu-Davis was appointed as Director at Phreesia, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 13, 2023, the Board of Directors (the "Board") of Phreesia, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Lisa Egbuonu-Davis to the Board.

View on SEC.gov

Phreesia, Inc. filing history →

Source: SEC EDGAR

accession 0001412408-23-000095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.